CD4 and non-small cell lung carcinoma: Compared to CD161-CD4+ T cells, CD161+CD4+ T cells from NSCLC tumors expressed higher frequencies of CD69, CD96, CD30L, OX40, PD-1-positive cells and lower frequencies of 4-1BB, CD27 and Tim-3.